Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
Status:
Terminated
Trial end date:
2008-03-05
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe.
The aim of this research study is to compare the efficacy of adding inhaled preprandial
insulin to metformin compared to adding rosiglitazone to metformin for the treatment of type
2 diabetes and to verify its safety (hypoglycaemia, pulmonary function, body weight, insulin
antibodies and side effects).